Holen Sie sich die Stockscreener-App
24.73
3.16%
1.01
Schlusskurs vom Vortag:
$23.72
Offen:
$23.85
24-Stunden-Volumen:
109.75K
Relative Volume:
0.18
Marktkapitalisierung:
$889.47M
Einnahmen:
$13.00M
Nettoeinkommen (Verlust:
$-68.87M
KGV:
-11.10
EPS:
-2.2276
Netto-Cashflow:
$-76.68M
1W Leistung:
+11.23%
1M Leistung:
-7.66%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$23.75
$24.71
1-Wochen-Bereich:
$22.08
$25.00
52-Wochen-Spanne:
$13.88
$33.20
Evommune Inc Stock (EVMN) Company Profile
Firmenname
Evommune Inc
Sektor
Branche
Telefon
(650) 223-7745
Adresse
1841 PAGE MILL RD, PALO ALTO
Compare EVMN vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVMN
Evommune Inc
|
24.70 | 854.36M | 13.00M | -68.87M | -76.68M | -2.2276 |
VRTX
Vertex Pharmaceuticals Inc
|
433.89 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.12 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.85 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.40 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.62 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Evommune Inc Stock (EVMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Eingeleitet | Oppenheimer | Outperform |
| 2026-01-08 | Eingeleitet | Raymond James | Strong Buy |
| 2026-01-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-12-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-12-01 | Eingeleitet | Evercore ISI | Outperform |
| 2025-12-01 | Eingeleitet | Leerink Partners | Outperform |
| 2025-12-01 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-12-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Evommune Inc Aktie (EVMN) Neueste Nachrichten
Evommune to Host KOL Webinar on April 13, 2026 Highlighting the Potential of MRGPRX2 Inhibition in Migraine - The Joplin Globe
Capricorn Fund Managers Ltd Acquires Shares of 60,000 Evommune, Inc. $EVMN - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
Evommune, Inc. (NYSE:EVMN) Receives Average Recommendation of "Buy" from Analysts - marketbeat.com
EVMN 8-K & SEC Filings - Yahoo Finance Australia
Evommune (EVMN) Institutional Ownership 2026 - MarketBeat
Evommune, Inc. (EVMN) Stock Price Quote Today & Current Price Chart - Capital.com
Evommune, Inc. (EVMN) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Corvus leads drug developers as index climbs in early 2026 - BioWorld MedTech
Evommune (NYSE:EVMN) Trading Up 10.2%Still a Buy? - MarketBeat
Evommune (NYSE:EVMN) Stock Price Down 7.6%Should You Sell? - marketbeat.com
This Evommune analyst begins coverage on a bullish note; here are top 5 initiations for Wednesday - MSN
Evommune, Inc.(NYSE: EVMN) added to S&P Global BMI Index - MarketScreener
EVMN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Planet Labs (NYSE:PL) Revenue Beats, Lags NYSE Index on Profit - Kalkine Media
Evommune (NYSE:EVMN) Upgraded at Clear Str - MarketBeat
Evommune stock sees RS rating rise to 91 - MSN
Nvidia To Rally Around 79%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm
Technical Analysis of Evommune, Inc. (NYSE:EVMN) - TradingView
Evommune (EVMN) Insider Trading Activity 2026 - MarketBeat
Analysts Set Expectations for Evommune FY2027 Earnings - MarketBeat
Evommune: Buy Rating Backed by 2026 Catalyst Rich Pipeline and Differentiated MRGPRX2 Dermatology Franchise - TipRanks
H.C. Wainwright cuts Evommune stock price target on dilution - Investing.com UK
H.C. Wainwright cuts Evommune stock price target on dilution By Investing.com - Investing.com India
HC Wainwright Cuts Evommune (NYSE:EVMN) Price Target to $50.00 - MarketBeat
Evommune (EVMN) Stock Forecast and Price Target 2026 - MarketBeat
This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
EVMN Stock: HC Wainwright & Co. Lowers Price Target to $50 | EVM - GuruFocus
Clear Street initiates Evommune stock with buy rating on drug potential - Investing.com India
Clear Street initiates Evommune stock with buy rating on drug potential By Investing.com - Investing.com South Africa
Evommune (NYSE:EVMN) Stock Price Up 7.5%Should You Buy? - MarketBeat
Evommune, Inc. Common Stock (NY: EVMN - The Chronicle-Journal
Evommune, Inc. Common Stock (NYSE:EVMN) Stock Quote - The Chronicle-Journal
Leerink reiterates Evommune stock rating after conference chat By Investing.com - Investing.com India
Leerink reiterates Evommune stock rating after conference chat - Investing.com Nigeria
RBC Capital initiates Evommune stock with outperform rating By Investing.com - Investing.com Canada
RBC Capital initiates Evommune stock with outperform rating - Investing.com
Evommune, Inc. (NYSE:EVMN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
1 Under‑the‑Radar Biotech to Buy for Potential 10X Growth in the Next Decade - AOL.com
Finanzdaten der Evommune Inc-Aktie (EVMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):